- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
N-Methyl-1,2-benzenediamine dihydrochloride
Product Name:N-Methyl-1,2-benzenediaminis dihydrochloridis
Formulae hypotheticae: C7H11ClN2
Molecular pondus:158.63
CAS Subcriptio Number:25148-68-9
![(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H-1,2 ,3-triazol-2-yl)](/upload/6698/-s-2-5-chloro-4-methyl-1h-benzo-d-imidazol-2-yl-2-methylpyrrolidin-1-yl-5-methoxy-2-2h-1-2-3-triazol-2-yl-_979142.gif "(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H-1,2 ,3-triazol-2-yl)")
(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H-1,2 ,3-triazol-2-yl)
Product Name:(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin- 1-yl)(5-methoxy-2-(2H- 1,2,3-triazol-2-yl)
Formulae hypotheticae: C23H24Cl2N6O2
Molecular pondus:487.39
CAS Registry Number: 1792993-84-0
Polyethylene Glycol
Product Name: Polyethylene Glycol
Formulae hypotheticae: N/A
Pondus hypotheticum: 0
CAS Registry Number: 25322-68-3
Starch
Product Name: Starch
Formulae hypotheticae:(C6H10O5)n
CAS Subcriptio Number: 9005-25-8
SODIUM CROSCARMELLOSE
Product Name: CROSCARMELLOSE SODIUM
Formulae hypotheticae: Null
CAS Registry Number: 74811-65-7
Sodium carboxyl methylstarch
Product Name: Sodium carboxyl methylstarch
Formula hypothetica: C2H4O3·xNa·x
CAS Subcriptio Number: 9063-38-1
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
